Efrat Dotan
Co-Director · University of Pennsylvania Health System
Credentials: · · · ·
History
- Present
MD | Hematology Oncology | Activity Co-Director · University of Pennsylvania Health System
2005–2007
Research
The Lancet Oncology · 2020 · 1,293 citations
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 1,081 citations
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2017 · 795 citations
- SC
14 papers

13 papers

10 papers · 3 as a resident

10 papers

10 papers · 1 as a fellow
- WT
10 papers

9 papers · 2 as a resident

9 papers
Grants
- 2021–2024
Neoadjuvant Stroma Modification in Pancreatic Cancer
National Cancer Institute · R21
PI · $459.6K · Research Inst of Fox Chase Can Ctr
Clinical trials
- 2020–2026
Principal investigator · Active not recruiting · Phase 2
ECOG-ACRIN Cancer Research Group
- 2016–2017
Principal investigator · Terminated · Phase 1
Fox Chase Cancer Center
- 2013–2015
Principal investigator · Terminated
Fox Chase Cancer Center
- 2010–2013
Principal investigator · Terminated · Phase 1
Fox Chase Cancer Center


